New Pharmacogenomics Study Findings Have Been Reported by Researchers at University of Belgrade (Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia)

MLA

“New Pharmacogenomics Study Findings Have Been Reported by Researchers at University of Belgrade (Pharmacogenomic Markers of Glucocorticoid Response in the Initial Phase of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia).” Biotech Week, 26 Sept. 2018, p. 247. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.555293592&authtype=sso&custid=ns315887.

APA

New Pharmacogenomics Study Findings Have Been Reported by Researchers at University of Belgrade (Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia). (2018, September 26). Biotech Week, 247.

Chicago

Biotech Week. 2018. “New Pharmacogenomics Study Findings Have Been Reported by Researchers at University of Belgrade (Pharmacogenomic Markers of Glucocorticoid Response in the Initial Phase of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia),” September 26. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.555293592&authtype=sso&custid=ns315887.